Rompen, Ingmar F.
Schütte, Isabel
Crnovrsanin, Nerma
Schiefer, Sabine
Billeter, Adrian T.
Haag, Georg Martin
Longerich, Thomas
Czigany, Zoltan
Schmidt, Thomas
Billmann, Franck
Sisic, Leila
Nienhüser, Henrik
Funding for this research was provided by:
Universitätsklinikum Heidelberg
Article History
Received: 21 March 2024
Accepted: 16 June 2024
First Online: 5 July 2024
Disclosure
: G.M.H. reports a Consulting or Advisory Role for Bristol-Myers Squibb; MSD Sharp and Dohme, Lilly, Novartis, Daiichi Sankyo, Servier, Pierre Fabre, Astra Zeneca and Swiss Cancer League, honoraria for lectures or from Servier, MSD Sharp and Dohme, Lilly, Targos, Bristol-Myers Squibb, Astra Zeneca and MCI Conventions, research funding by DKFZ Heidelberg and MSD Sharp and Dohme, travel support/accommodations by Bristol-Myers Squibb Lilly Servier, MSD Sharp and Dohme and Daiichi Sankyo. All other authors report no conflicts of interest.